Literature DB >> 21112200

Routes to manipulate MHC class II antigen presentation.

Tineke van den Hoorn1, Petra Paul, Marlieke L M Jongsma, Jacques Neefjes.   

Abstract

MHC class II molecules (MHC-II) present antigenic fragments acquired in the endocytic route to the immune system for recognition and activation of CD4+ T cells. This ignites a series of immune responses. MHC-II strongly correlates to most autoimmune diseases. Understanding the biology of MHC-II is therefore expected to translate into novel means of autoimmunity control or immune response improvement. Although the basic cell biology of MHC-II antigen presentation is well understood, many novel aspects have been uncovered in recent years including means of antigen delivery, preparation for MHC-II loading, transport processes and vaccination strategies. We will discuss past, present and future of these insights into the biology of MHC-II.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112200     DOI: 10.1016/j.coi.2010.11.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  29 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

Review 2.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Authors:  Elena Lorente; Ruth García; Daniel López
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

Review 4.  HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Authors:  Barbara Seliger; Matthias Kloor; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

Review 5.  Mechanisms of peptide repertoire selection by HLA-DM.

Authors:  Wouter Pos; Dhruv K Sethi; Kai W Wucherpfennig
Journal:  Trends Immunol       Date:  2013-07-05       Impact factor: 16.687

6.  Resolving multiple protein-peptide binding events: implication for HLA-DQ2 mediated antigen presentation in celiac disease.

Authors:  Jianhao Wang; Xi Jin; Jiahui Liu; Chaitan Khosla; Jiang Xia
Journal:  Chem Asian J       Date:  2012-03-12

Review 7.  Determinants of immunodominance for CD4 T cells.

Authors:  AeRyon Kim; Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2015-01-08       Impact factor: 7.486

Review 8.  Unconventional recognition of peptides by T cells and the implications for autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Nat Rev Immunol       Date:  2012-09-07       Impact factor: 53.106

9.  CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.

Authors:  Vera Rocha-Perugini; Gloria Martínez Del Hoyo; José María González-Granado; Marta Ramírez-Huesca; Virginia Zorita; Eric Rubinstein; Claude Boucheix; Francisco Sánchez-Madrid
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

Review 10.  Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.

Authors:  Jianmin Zuo; Martin Rowe
Journal:  Viruses       Date:  2012-08-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.